Register for Digital Look

Company Announcements

AGM Resolutions

Related Companies


RNS Number : 8953W
Clinigen Group plc
17 November 2017

17 November 2017




AGM Resolutions

On 12 October 2017 Clinigen Group plc (AIM:CLIN, "Clinigen" or "the Group") published the Notice convening the Group's 2017 Annual General Meeting ("AGM"), which is to be held on 28 November 2017 at 10.00am. Also on 12 October 2017, this Notice, and a letter from the Chairman, were posted to shareholders, accompanied by a copy of the 2017 Annual Report.

Clinigen confirms that, consistent with the statement made in the Remuneration Report contained within the 2017 Annual Report, it is intended that at the forthcoming AGM the Group's remuneration policy, as set out in the Remuneration Report, will be put forward, on an advisory basis, for shareholder approval. Shareholders who wish to vote on the Group's remuneration policy will need to attend the AGM and vote in person.


- Ends-


Clinigen Group plc

Tel: +44 (0) 1283 495 010

Shaun Chilton, Group Chief Executive Officer

Martin Abell, Group Chief Financial Officer

Matt Parrish, Head of Investor Relations

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Tom Ballard (Corporate Broking)

RBC Capital Markets - Joint Broker

Tel: +44 (0) 20 7653 4000

Marcus Jackson / Elliot Thomas / Jack Wood

Instinctif Partners (media relations)

Tel: +44 (0) 20 7457 2020

Melanie Toyne-Sewell / Alex Shaw / Deborah Bell




About Clinigen Group

Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combination of businesses focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. Clinigen acquired Quantum Pharma in November 2017.


For more information, please visit


This information is provided by RNS
The company news service from the London Stock Exchange

Top of Page